These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7634114)

  • 1. Are Proventil Repetabs and Volmax therapeutically equivalent?
    Welborn MW; Connelly JF
    Am J Health Syst Pharm; 1995 Apr; 52(8):798, 800-1. PubMed ID: 7634114
    [No Abstract]   [Full Text] [Related]  

  • 2. Albuterol extended-release products: a comparison of steady-state pharmacokinetics.
    Hussey EK; Donn KH; Powell JR
    Pharmacotherapy; 1991; 11(2):131-5. PubMed ID: 2052468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albuterol extended-release products: effect of food on the pharmacokinetics of single oral doses of Volmax and Proventil Repetabs in healthy male volunteers.
    Hussey EK; Donn KH; Powell JR; Lahey AP; Pakes GE
    J Clin Pharmacol; 1991 Jun; 31(6):561-4. PubMed ID: 1880222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved stability in oral delivery of albuterol provides less variability in bronchodilation in adults with asthma.
    Grossman J; Morris RJ; White KD; Cocchetto DM
    Ann Allergy; 1991 Apr; 66(4):324-7. PubMed ID: 2014933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic characteristics of a novel controlled-release sprinkle formulation of salbutamol.
    Mulligan S; Devane J; Martin M
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():312-4. PubMed ID: 1820899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-release albuterol in the treatment of 6- to 12-year-old asthmatic children.
    Skoner DP; Boltansky H; Kobayashi RH; Pearlman DS; Shapiro G; Harrison JE; Trochelmann LM; Lorber RR
    Ann Allergy Asthma Immunol; 1996 May; 76(5):462-8. PubMed ID: 8630721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Interval Between Actuations of Albuterol Hydrofluoroalkane Pressurized Metered-Dose Inhalers on Their Aerosol Characteristics.
    Berlinski A; Pennington D
    Respir Care; 2017 Sep; 62(9):1123-1130. PubMed ID: 28611228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FDA-mandated trial of safety of long-acting beta-agonists in asthma: finality or futility?
    Sears MR
    Thorax; 2013 Feb; 68(2):195-8. PubMed ID: 22858928
    [No Abstract]   [Full Text] [Related]  

  • 9. Isoetherine or albuterol for acute asthma.
    Finkelstein F
    Am J Med; 1997 Jan; 102(1):130. PubMed ID: 9209213
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety of long-acting beta-agonists: are new data really required?
    Sears MR
    Chest; 2009 Aug; 136(2):604-607. PubMed ID: 19505986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Full-day ADHD symptom control that "lasts from home to homework".
    Pediatr Nurs; 2000; 26(6):634-5. PubMed ID: 12026370
    [No Abstract]   [Full Text] [Related]  

  • 12. The recent paper by Daley-Yates et al.
    Fuglsang A; Thyroff-Friesinger U; Gross J
    Clin Ther; 2009 Aug; 31(8):1881-2; author reply 1882-4. PubMed ID: 19808147
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo-in vitro correlation of salbutamol release from a controlled release osmotic pump delivery system.
    Civiale C; Ritschel WA; Shiu GK; Aiache JM; Beyssac E
    Methods Find Exp Clin Pharmacol; 1991 Sep; 13(7):491-8. PubMed ID: 1784147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The need for additional metrics to assess therapeutic equivalence of some multiphasic modified-release products.
    Kondra PM; Endrenyi L; Tothfalusi L
    Clin Ther; 2011 Sep; 33(9):1214-9. PubMed ID: 21849209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a holding chamber on albuterol metered-dose inhaler product differences.
    Johnson JL; Guthrie D; Hyde J; Hanson T; Karlage K; Myrdal PB
    Ann Allergy Asthma Immunol; 2016 Sep; 117(3):246-50. PubMed ID: 27613457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Are there any advantages of a fixed combination in the treatment of asthma with respect to safety and tolerability?].
    Virchow C
    Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S376-80. PubMed ID: 19941240
    [No Abstract]   [Full Text] [Related]  

  • 17. United States Food and Drug Administration requirements for approval of generic drug products.
    Meyer MC
    J Clin Psychiatry; 2001; 62 Suppl 5():4-9; discussion 23-4. PubMed ID: 11305846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of asthma with salmeterol--a new prolonged-action inhalatory beta 2 agonist].
    Dahl R; Pedersen B
    Ugeskr Laeger; 1991 Oct; 153(44):3098-100. PubMed ID: 1683037
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed-release prednisone (Rayos).
    Med Lett Drugs Ther; 2012 Nov; 54(1404):94. PubMed ID: 23183387
    [No Abstract]   [Full Text] [Related]  

  • 20. The article by Daley-Yates et al.
    Crompton GK
    Clin Ther; 2010 May; 32(5):996-7; author reply 997-1000. PubMed ID: 20685508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.